UBE3A regulates the transcription of IRF, an antiviral immunity

Human Molecular Genetics
Ryohei FurumaiToru Takumi


UBE3A is a gene responsible for the pathogenesis of Angelman syndrome (AS), a neurodevelopmental disorder characterized by symptoms such as intellectual disability, delayed development and severe speech impairment. UBE3A encodes an E3 ubiquitin ligase, for which several targets have been identified, including synaptic molecules. Although proteolysis mainly occurs in the cytoplasm, UBE3A is localized to the cytoplasm and the nucleus. In fact, UBE3A is also known as a transcriptional regulator of the family of nuclear receptors. However, the function of UBE3A in the nucleus remains unclear. Therefore, we examined the involvement of UBE3A in transcription in the nuclei of neurons. Genome-wide transcriptome analysis revealed an enrichment of genes downstream of interferon regulatory factor (IRF) in a UBE3A-deficient AS mouse model. In vitro biochemical analyses further demonstrated that UBE3A interacted with IRF and, more importantly, that UBE3A enhanced IRF-dependent transcription. These results suggest a function for UBE3A as a transcriptional regulator of the immune system in the brain. These findings also provide informative molecular insights into the function of UBE3A in the brain and in AS pathogenesis.


Jun 18, 2020·International Journal of Molecular Sciences·Chuanyin LiRonggui Hu
Nov 3, 2020·Translational Science of Rare Diseases·Firas AlqarajehCarlos R Ferreira


Mar 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·J M HuibregtsePeter M Howley
Jan 1, 1997·Nature Genetics·T KishinoJoseph Wagstaff
Sep 1, 1997·Nature Genetics·T H Vu, A R Hoffman
Nov 25, 2000·Molecular Cell·K SengerD Thanos
Feb 15, 2001·Oncogene·R S ChapmanC J Watson
Jun 8, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·T M Tikka, J E Koistinaho
Mar 16, 2002·Neurobiology of Disease·Kiyonori MiuraJoseph Wagstaff
Jun 12, 2003·Nucleic Acids Research·Kay S Childs, Stephen Goodbourn
Aug 4, 2004·Archives of General Psychiatry·Alan S BrownEzra S Susser
Oct 30, 2004·European Journal of Biochemistry·Sang-Youel ParkDai-Wu Seol
Nov 17, 2004·Annals of Neurology·Diana L VargasCarlos A Pardo
Nov 24, 2004·Lancet Neurology·V Wee YongLuanne M Metz
Nov 30, 2005·The Journal of Biological Chemistry·Lu LiDavid B Sacks
Feb 14, 2006·American Journal of Medical Genetics. Part a·Charles A WilliamsJoseph Wagstaff
Oct 5, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Stephen E P SmithPaul H Patterson
Nov 27, 2008·The Biochemical Journal·Susanne PetterssonKathryn L Ball
Jul 8, 2009·Pediatrics·Hjördís O AtladóttirErik T Parner
Jun 24, 2010·European Journal of Human Genetics : EJHG·Daren Low, Ken-Shiung Chen
Oct 13, 2010·BMC Neurology·Carlo ParibelloDouglas W Ethell
May 18, 2011·Molecular and Cellular Biology·Flávia R G CarneiroJoão P B Viola
May 20, 2011·Trends in Neurosciences·Angela M MabbBenjamin D Philpot
Jul 27, 2011·Journal of Neurodevelopmental Disorders·Toru Takumi
Oct 7, 2011·Science Translational Medicine·Stephen E P SmithMatthew P Anderson

Related Concepts

Genome-Wide Association Study
Interferon Regulatory Factors
Transcriptional Regulation
Transcription, Genetic
Transcription, RNA-dependent
Neurodevelopmental Disorders
Speech Disorders

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.


Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Angelman Syndrome

Angelman syndrome is a neurogenetic imprinting disorder caused by loss of the maternally inherited UBE3A gene and is characterized by generalized epilepsy, limited expressive speech, sleep dysfunction, and movement disorders. Here is the latest research.